0
United States ( Change Country )

Aurora A Inhibitor I

Catalog No.S1451 1 Review(s)
Price Stock Quantity
$ 120
$ 210
$ 670
 
processing...
You can order by phone, email or fax

Tel: +1-832-582-8158    Fax: +1-832-582-8590
Email: sales@selleckchem.com

Free Overnight Delivery on all orders over $ 500.

Order Aurora A Inhibitor I now
and get it on .

Aurora A Inhibitor I Chemical Structure

  • VX-680 (MK-0457, Tozasertib)

    VX-680 (MK-0457, Tozasertib) is the inhibitor of Aurora-A,-B,-C kinases with apparent inhibition constant values of 0.6,18,4.6 nM respectively.

  • MLN8054

    MLN8054 is an Aurora inhibitor, Aurora A (IC50 = 0.004 uM) over Aurora B (IC50 = 0.172 uM).

  • ZM-447439

    ZM-447439 is a poten, selective ATP-competitive Aurora B kinase inhibitor with an IC50 of 50 nM, 1 μM and 250 nM for Aurora B, A and C, respectively.

  • Danusertib (PHA-739358)

    Danusertib (PHA-739358) is a pyrrolo-pyrazole and small molecule aurora kinases and Bcr-Abl kinase inhibitor for aurora A, B, and C with IC50 of 13 nM, 79 nM, and 61 nM, respectively.

  • MLN8237 (Alisertib)

    MLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.

  • AT9283

    AT9283 is a small molecule a multi-targeted c-ABL, JAK2, Aurora A and B inhibitor with IC50 of 4, 1.2, 1.1 and approximate 3 nM for Bcr-Abl(T3151), Jak2 and Jak3, aurora A and B, respectively.

  • AZD1152-HQPA (Barasertib)

    AZD1152-HQPA (Barasertib) is a highly potent and selective inhibitor of Aurora B (Ki, 0.36 nM)

  • SNS-314

    SNS-314 Mesylate is a potent and selective Aurora kinase inhibitor with IC50 of 9, 31, and 3.4 nM for Aurora kinases A, B, and C, respectively.

  • CYC116

    CYC116 is an Aurora kinase/VEGFR2 inhibitor

  • ENMD-2076

    ENMD-2076 is a antiangiogenic and Aurora kinase inhibitor with IC50 of 3, 13, 350, 23, 40, 93 and 120 nM for Flt-3, AurA, AurB, Src, KDR/VEGFR2 and FGFR1.

Biological Activity

Information Aurora A Inhibitor I is a novel, potent, and selective inhibitor to Aurora A with IC50 of 3.4 nM.
Targets Aurora A Aurora B Aurora C
IC50 3.4 nM 3.4 μM [1] 0.432 μM [2]
In vitro Aurora A Inhibitor I is a 2,4-dianilinopyrimidine that selectively and potently inhibits Aurora A. Aurora A Inhibitor I effectively inhibits the proliferation of HCT116 and HT29 cells, with IC50 of 190 nM and 2.9 μM, respectively. The Aurora A selectivity of Aurora A Inhibitor I against Aurora B depends on a single amino acid (Thr217) of Aurora A. [1] In KCL-22 cells, Aurora A Inhibitor I (1–5 μM) increases G2/M cell fraction, induces histone H3 serine 10 phosphorylation, and suppresses mitotic Aurora A autophosphorylation on Thr288. Aurora A Inhibitor I (0.5–5 μM) also suppresses cell proliferation in KCL-22 cells, as well as BCR-ABL-negative leukemia cell lines KG-1 and HL-60. Aurora A Inhibitor I effectively induces apoptosis in KCL-22 cells at 5 μM. [2] In a recent study, Aurora A Inhibitor I is also found to inhibit cell growth of HCT116, HT29, and HeLa cells, with IC50 of 377.6 nM, 5.6 μM, and 416 nM. [3]
In vivo
Clinical Trials
Features Aurora A Inhibitor I is a novel, potent, and selective inhibitor to Aurora A.

Protocol

Kinase Assay: [1]

Auroras A and B Inhibition Assays Both Auroras A and B are assayed in ELISA format using a GST fusion (pGEX-4T) of the N-terminus of Histone H3 (aa 1−18) as substrate. Plates are coated with 2 μg/mL substrate in PBS then blocked with 1 mg/mL I-block in PBS. Kinase reactions are run for 40 min with 5 ng/mL (0.16 nM) Aurora A or 45 ng/mL (1.1 nM) Aurora B at 30 μM ATP (~ Km) in kinase buffer. Final DMSO concentration is 4%. Product is detected by incubation with antiphosphohistone H3 (Ser10) 6G3 mouse monoclonal antibody and sheep-anti-mouse HRP conjugate, followed by washing and addition of TMB substrate. After quenching with 1 M phosphoric acid, plates are read at 450 nM.

Cell Assay: [1]

Cell lines: HCT116 and HT29 cells
Concentrations: 0.1 nM–10 μM, dissolved in medium lacking serum and glutamine (dissolved in DMSO as stock solution)
Incubation Time: 72 hours
Method: Cells are seeded in 384-well plates on day 0 in 50 μL of complete medium and incubated overnight in a 5% CO2 atmosphere at 37 ℃. On day 1, 10 μL of Aurora A Inhibitor I is added. On day 4, plates are allowed to reach room temperature, and 30 μL Cell Titer-Glo reagent is added to each well to measure total ATP levels. Plates are read after shaking 15 min at room temperature.

References

Molecular Weight (WM): 588.07
Formula:

C31H31ClFN7O2

CAS No.: 1158838-45-9
Synonyms:
N/A
Dissolve in (25°C): DMSO ≥118mg/mL 
Water <1mg/mL 
Ethanol <1mg/mL 
Storage: 2 years-20°CPowder
1 week-4°Cin DMSO
1 month-80°in DMSO

Related Inhibitors

Recommended Screening Libraries

We have 1 customer reviews of Aurora A Inhibitor I.

  • (0)
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Average Customer Review

(1 customer reviews)

  • Click to enlarge

    Western blot analysis of Histone and p-Histone. 0-10μM Aurora inhibitor I was added.

     

     

  • Western blot analysis of Histone and p-Histone. 0-10μM Aurora inhibitor I was added.

     

     

  • Data independently produced by Dr. Zhang of Tianjin Medical University
    Aurora A Inhibitor I purchased from Selleck

Our scientific support team are available to answer any questions or queries.
Fill out an inquiry form for Aurora A Inhibitor I for help.

Quality Matters

Check our customer reviews


Western blot analysis of Histone and p-Histone. 0-10μM Aurora inhibitor I was added.

 

 

Data independently produced by Dr. Zhang of Tianjin Medical University

Free Sample and Reward

We give free samples and rewards to people who would like to provide us useful scientific data(western blot, etc.) > See Details

Recently Viewed Items

Keywords:buy Aurora A Inhibitor I | Aurora A Inhibitor I supplier | purchase Aurora A Inhibitor I | Aurora A Inhibitor I cost | Aurora A Inhibitor I manufacturer | order Aurora A Inhibitor I | Aurora A Inhibitor I distributor